First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.1663 USD 0.73% Market Closed
Updated: Mar 29, 2024

Sonoma Pharmaceuticals Inc
Revenue

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Sonoma Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Revenue
$12.3m
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Johnson & Johnson
NYSE:JNJ
Revenue
$85.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$45B
CAGR 3-Years
2%
CAGR 5-Years
15%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$58.5B
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$60.1B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Revenue
$34.1B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
4%

See Also

What is Sonoma Pharmaceuticals Inc's Revenue?
Revenue
12.3m USD

Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Revenue amounts to 12.3m USD.

What is Sonoma Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%

Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Sonoma Pharmaceuticals Inc have been -16% over the past three years , -8% over the past five years , and -1% over the past ten years .